Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Louise M Bolton
Activity of EGFR, mTOR and PI3K Inhibitors in an Isogenic Breast Cell Line Model
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates
Cancer Research
Cancer Research
Oncology
Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination With Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling
Cancer Discovery
Oncology
Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
The Impact of PI3K Inhibitors on Breast Cancer Cell and Its Tumor Microenvironment
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Cell Migration Induced by Native Type IV Collagen Requires PI3K/Akt2 and EGFR Activity in MDA-MB-231 Breast Cancer Cells
Cancer Research Journal
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
